Lemaitre Vascular (LMAT) 14.82 $LMAT Hologic: FDA Okays

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 12:08 AM

Lemaitre Vascular (LMAT) 14.82 $LMAT

Hologic: FDA Okays Procleix Zika Virus Test under IND Study
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:51AM CDT
Hologic's (HOLX) Procleix Zika Virus Test was approved under FDA???s Investigational New Drug (IND) study protocol to detect the presence of Zika virus in donated blood.
ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HOLX: 35.62 (+1.51)

Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:26AM CDT
On Jun 22, 2016, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA).
WBA: 85.06 (+1.32), LMAT: 14.82 (+0.13), STJ: 78.49 (+0.82), NUVA: 58.86 (+1.07)

Qiagen's Q1 Results Hit by Currency, Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:32AM CDT
Qiagen (QGEN) is facing increasing competition from firms that provide pre-analytical solutions and other products.
BSX: 22.97 (+0.31), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), QGEN: 22.39 (+0.64)

Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07), HRC: 52.06 (+0.78)

Hologic's Zika Virus Test Gets FDA Nod for Emergency Use
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:58AM CDT
Hologic (HOLX) will run the Aptima Zika virus test on its market leading Panther platform, which substantially reduces hands-on time for laboratories and the potential for manual errors.
ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HOLX: 35.62 (+1.51)

AmSurg, Envision Healthcare Set to Merge by 2016-End
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Envision shareholders will own 53% of the combined entity while AmSurg (AMSG) shareholders will have 47%.
AMSG: 81.67 (+0.64), EVHC: 26.68 (+0.10), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13)

Genomic Health Brings Liquid Biopsy Test for Stage IV Cancer
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:13AM CDT
Genomic's (GHDX) Oncotype SEQ facilitates personalized treatment of patients suffering from stage four solid tumor cancer.
BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), ILMN: 146.59 (+5.70), GHDX: 26.59 (+0.11)

Qiagen???s QIAsure Test to Determine Cervical Cancer Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:33AM CDT
Qiagen's (QGEN) QIAsure accurately stratifies cervical cancer risk, which offers highly sensitive and specific results for patients and clinicians.
BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), QGEN: 22.39 (+0.64), NUVA: 58.86 (+1.07)

Boston Scientific: NICE Backs GreenLight XPS for BPH Cure
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:01AM CDT
As per NICE's estimates, broad adoption of Boston Scientific's (BSX) GreenLight therapy over TURP can lead to savings of up to ??3.2 million annually for the National Health Service (NHS).
BSX: 22.97 (+0.31), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)

Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), BRKR: 24.40 (+0.14), NUVA: 58.86 (+1.07)

Boston Scientific: Restructuring Plan, Global Growth Impress
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 6:14AM CDT
On Jun 13, 2016, we issued an updated research report on Boston Scientific Corporation (BSX).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13)

PetMed Remains Strong on New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 10:15AM CDT
On Jun 13, 2016, we issued an updated research report on PetMed Express (PETS).
ICUI: 108.13 (+3.15), PETS: 18.50 (+0.09), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)

Haemonetics: Q4 Hit by Issues in Russia, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:51AM CDT
Haemonetics (HAE) posted a dismal fourth-quarter fiscal 2016 with both EPS and revenues failing to meet the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), HAE: 30.17 (+0.35), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13)

Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:20AM CDT
Hill-Rom (HRC) posted a mixed second quarter of fiscal 2016 with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same.
BSX: 22.97 (+0.31), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HRC: 52.06 (+0.78)

Hologic: Q2 Strong on Segmental Expansion, Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:43AM CDT
Hologic (HOLX) ended second-quarter fiscal 2016 on a promising note, squarely beating the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HOLX: 35.62 (+1.51)

Mead Johnson: Strong Q1 on Overseas Growth & Strategies
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 6:40AM CDT
Mead Johnson (MJN) embarked on a promising journey this year, posting square beats in the first quarter.
BSX: 22.97 (+0.31), MJN: 88.61 (+1.16), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13)

Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 108.13 (+3.15), ABAX: 47.11 (+1.81), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)

Henry Schein: Q1 Results Strong, Expansion Plans on Track
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:02AM CDT
Henry Schein (HSIC)made an impressive start to 2016, with its top and bottom line beating the Zacks Consensus Estimate in the first quarter.
BSX: 22.97 (+0.31), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HSIC: 177.61 (+2.66)

Medtronic (MDT) Posts Solid Q4; Covidien Synergy Continues
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 6:31AM CDT
On Jun 3, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)

Medtronic (MDT) Beats Q4 Earnings & Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:01AM CDT
Medtronic's (MDT) fourth-quarter fiscal 2016 adjusted earnings per share (EPS) came in at $1.27, a penny ahead of the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thunes, UnionPay Revamp China Payments with $10K Daily

Unveiling a New Era for Cross-Border Payments Thunes is shaking things up, unleashing a fresh wave of possibilities for moving money into China's mainland. In a strategic twist, Thunes has teamed up with UnionPay International, aiming to transform the cross-border payment experience. With a potent combo of bank-grade security and hefty daily transaction limits, this...

Orthocell's Remplir™ Hits Record U.S. Sales in October

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

RD Technologies Ramps Up Cross-Border Payments

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Extend Your Water Heater's Life with Anode Care

Small Component, Big Impact: The Anode Rod Picture this: You’ve got a trusty water heater keeping your showers steamy, but lurking inside is a villain called rust. Enter the unsung hero—the anode rod. It might not be glamorous, but this little piece of metal works overtime to save your tank from a watery grave. Tim Fessler and Dave Super, seasoned plumbing hotshots...

Roof Flashing Insights with Expert Jeremiah Lightsey

Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...

Gildan Faces Class Action Deadline Over Fraud Claims

Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...

Mastering Progressive Overload: Break Workout Plateaus

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

Perion Acquisition: Affle's Bold Leap in Ad Tech

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Potatoes vs. Candy: Halloween's Spuddy Surprise

When Halloween rolls around, you expect rabid kids clamoring for candy corn and chocolate bars. But this year, Idaho threw a spud into the sweets machine. Idaho's Potatoes Steal the Show In an unexpected twist, the Idaho Potato Commission ran a zany experiment on Halloween: kids had to choose between their beloved Halloween candy and a genuine Idaho potato. Imagine the...